Wockhardt Ltd
Dr. Khokan Debnath is a highly experienced professional in the field of clinical operations, regulatory affairs, pharmacovigilance, and quality assurance. With a strong background in managing end-to-end clinical research, Dr. Khokan has demonstrated expertise in overseeing clinical studies, regulatory compliance, and pharmacovigilance activities. Dr. Debnath has a track record of successfully leading teams, developing strategies, and ensuring the timely delivery of projects within defined timelines and budgets. Dr. Khokan's extensive experience in the pharmaceutical industry and academic achievements demonstrate their commitment to excellence in the healthcare sector.
This person is not in any offices
Wockhardt Ltd
1 followers
Wockhardt Limited is a pharmaceutical and biotechnology company. The Company's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. Its products include Ace Proxyvon, Bio-Corneum, Aceroc, Alphadopa, Biovac Typhoid, Acetic Acid Otic Solution, Amlodipine Besylate Tablets, Adenosine Injection, Amoxicillin and Clavulanate Potassium for Oral Suspension, Azithromycin Tablets, Aciclovir Powder for Injection, Alendronic Acid, Amitriptyline, Clarithromycin, Entacapone Tablet and Flucloxacillin Injection. It operates a chain of approximately 10 super specialty hospitals, which offer treatment and care facilities in cardiology, neurosurgery, orthopedics, critical care, oncology, nephrology, urology and others. It has over 10 manufacturing plants located in India, the United Kingdom, Ireland and the United States. The Company has approximately three research centers globally.